DRMAW vs OXY
Dermata Therapeutics Inc. Warrant (DRMAW) versus OXY (OXY) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
OXY (OXY) common stock.
DRMAW does not have a complete income-statement cache yet.
Latest reported OXY revenue for 2026-06-30 was $13.29B. Net income was $6.36B. OXY currently screens at market cap $0.
DRMAW currently screens at market cap $0. OXY currently screens at market cap $0.
Not investment advice. Open the DRMAW and OXY stock pages for the full models.
Not investment advice.